MMR vaccine

MMR vaccine

Mumps measles rubella vaccine
Combination of
Measles vaccine	Vaccine
Mumps vaccine	Vaccine
Rubella vaccine	Vaccine
Clinical data
Trade names	M-M-R II, Priorix, Tresivac, Trimovax, others
Synonyms	MPR vaccine[1]
AHFS/Drugs.com	Multum Consumer Information
ATC code	J07BD52 (WHO)
Legal status
Legal status	In general: ℞ (Prescription only)
NY (what is this?)  (verify)

The MMR vaccine is a vaccine against measles, mumps, and rubella (German measles).

The first dose is given to children around 9 to 15 months of age, with a second dose at 15 months o 6 years of age, with at least 4 weeks between the doses.^[2][3] After two doses 97% of people are protected against measles, 88% against mumps, and at least 97% against rubella.^[2]

The World Health Organisation sets a target of 95% needed to achieve and sustain measles elimination. In 2020/1 only 85.5% of five-year-olds in England were vaccinated.^[4]

The vaccine is also recommended in those who do not have evidence of immunity,^[2] and those with well controlled HIV/AIDS.^[5][6] It is given by injection.^[2]

1. ↑ Grignolio, Andrea (2018). Vaccines: Are they Worth a Shot?. Springer. p. 2. ISBN 9783319681061.
2. ↑ ^{2.0 2.1 2.2 2.3} "MMR Vaccination What You Should Know Measles, Mumps, Rubella". CDC. 2 February 2018. Retrieved 10 September 2018.
3. ↑ "Measles vaccines: WHO position paper – April 2017". Releve Epidemiologique Hebdomadaire. 92 (17): 205–27. 28 April 2017. PMID 28459148.
4. ↑ "A Fresh Shot". Policy Exchange. Retrieved 2023-10-20.
5. ↑ Kinney, Rebecca (2 May 2017). "Core Concepts - Immunizations in Adults - Basic HIV Primary Care - National HIV CurriculumImmunizations in Adults". www.hiv.uw.edu.
6. ↑ Watson, JC; Hadler, SC; Dykewicz, CA; Reef, S; Phillips, L (22 May 1998). "Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP)". MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports. 47 (RR-8): 1–57. PMID 9639369.